Verbatim response from Claude
Zepbound vs. Compounded Tirzepatide: Is the Brand Worth It?
The Core Trade-off
Zepbound (Eli Lilly) costs roughly $1,060/month without insurance, while compounded tirzepatide runs $150-400/month from various telehealth providers.
When Zepbound Is Worth It
- Guaranteed purity and dosing accuracy — FDA-regulated manufacturing with strict quality controls
- Consistent supply — no batch-to-batch variation
- Auto-injector pen — easier and more reliable than vials/syringes
- You have good insurance — many plans now cover it, bringing cost to $25-50/month
- Lilly's savings program — can bring it to ~$550/month commercially insured
When Compounded May Make Sense
- Cost is genuinely prohibitive and you'd otherwise go without
- Providers like Hims & Hers, BodyLogicMD, or Henry offer convenience
- Short-term bridge while insurance approval is pending
Important Cautions About Compounded
- The FDA has ended most compounded tirzepatide now that shortages are resolved
- Quality varies significantly between compounding pharmacies
- Some use tirzepatide salts (acetate/citrate) rather than the base compound — not equivalent
Bottom Line
If insurance covers it, absolutely choose Zepbound. If paying cash, the brand is meaningfully safer — but the price gap is real. Check Lilly's savings programs first before defaulting to compounded.